Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gallium-68-dotatate (netspot) (1 trial)
Neuroendocrine Tumors (Phase 2)
Trials (1 total)
Trial APIs (1 total)